Abhishek Basu
@AbhishekBasu86
Followers
45
Following
223
Media
1
Statuses
28
Pharmacologist, Postdoc Fellow at NIH
Bethesda, MD
Joined March 2023
RT @JCI_insight: ICYMI: Patients with pulmonary fibrosis have limited treatment options. @resatcinar @AbhishekBasu86 & team @IRPatNIH inve….
0
6
0
RT @JCI_insight: Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis by @resa….
0
2
0
RT @JCI_insight: Patients with pulmonary fibrosis have limited treatment options. @resatcinar @AbhishekBasu86 & team @IRPatNIH @IRPatNIH….
0
1
0
RT @resatcinar: 📣Our research @JCI_Insight highlights the key role of #cannabinoid receptor 1 (#CB1R) in #AlveolarMacrophages in promoting….
0
5
0
RT @medrxivpreprint: Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis #medRx….
0
2
0
RT @resatcinar: 🏆Congratulations to all awardees in #ICRS2023Toronto. I am also so proud that Szabolcs Dvoracsko and Natalie Johnson @nljoh….
0
3
0
RT @resatcinar: Last day of #ICRS2023Toronto. Successful meeting with exciting science, discussions and meeting with colleagues and friend….
0
3
0
RT @resatcinar: Exciting Monday for Cinar lab #ICRS2023Toronto with presententing. ✨Role of CB1R in pulmonary fibrosis. ✨Why inhalational….
0
7
0
RT @resatcinar: @AbhishekBasu86 presented an example why we need multi-target therapeutic approach to #curePF #cureHPS #ATS2023 with simu….
0
1
0
Presenting how inhalation delivery of MRI-1867 (zevaquenabant) can be a better therapeutic modality in pulmonary fibrosis at ATS 2023. #ATS2023 @NIAAAnews @resatcinar
1
1
11
RT @resatcinar: Our research @NIAAAnews published @AdvSciNews “An Integrative Multiomics Framework for Identification of Therapeutic Target….
0
4
0
RT @resatcinar: After 4 years, finally this weekend 45 scientists and clinicians meet again in-person @HPSNetwork Meeting to discuss exciti….
0
2
0
RT @muharif: Excited to attend my first Hermansky-Pudlak Syndrome (HPS) Network Conference. I will be presenting our work on HPS Pulmonary….
0
1
0
RT @tony_jourdan1: Happy to share our newest piece of work. Another step towards the come back of CB1R blockers! Thanks to @inversago for t….
0
4
0
RT @FrontNephrology: New Research: Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diab….
0
2
0
RT @resatcinar: 🥃 🫁Why lungs are more sensitive for immune dysregulation than liver with heavy alcohol drinking?. ❗️Please visit to learn t….
0
1
0
RT @resatcinar: ⏳Giving a short afternoon break to #KSFibrosis23 #KeystoneFibrosis2023 with learning outdoor E.C.M. activities in nature #B….
0
2
0
RT @NIAAAnews: Check out our major update to Alcohol Facts and Statistics! The expanded content is now presented on separate web pages for….
0
19
0
RT @resatcinar: 💊Why dual-target #CB1R and iNOS inhibition by #MRI1867 (#zevaquenabant) is an emerging clinical candidate for #PulmonaryFib….
0
2
0